• Accueil >
  • Publications >
  • Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial

Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial

1 avr. 2005Blood

DOI : 10.1182/blood-2004-07-2648

Auteurs

M. Schmidt